Articles On Immutep (ASX:IMM)

  To register for Friday's webinar click here. Krakatoa Resources (ASX:KTA) has announced that new niobium-REE gravity target has been identified at Mt Clere. The assays show an extensive 40 km long target catchment area potentially prospec...

Immutep (ASX:IMM) has announced initial encouraging data from EFTISARC-NEO, a Phase 2 investigator-initiated trial of eftilagimod alpha in combination with radiotherapy, a standard-of-care treatment, plus MSD's KEYTRUDA (pembrolizum...

ASX Health sector was in correction territory in April Why is the health sector different from other sectors? We look at the best performing ASX health stocks for the month   The S&P/ASX 200 Health Care [XHJ] had a soft month in April...

The S&P/ASX 200 Index (ASX: XJO) is on form again on Tuesday and pushing higher. At the time of writing, the benchmark index is up 0.2% to 7,651.4 points. Four ASX shares that have failed to follow the market higher today are listed b...

Pointsbet Holdings Ltd (ASX: PBH) shares are having a very tough session on Tuesday. In morning trade, the sports betting company's shares crashed as much as 45% to 45.5 cents. The company's shares have recovered a touch since then but rema...

A week or so ago, my young bloke's school invited parents to join the kids on a trip to the local cemetery, to take part in an ANZAC commemoration the school calls Honour Our Fallen. The kids were asked to talk about a family member who was...

There’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to control sebum production We look at the best and worst performing ASX health stocks in the past month   Scientists have made a significant b...

It was a mildly disappointing Wednesday for ASX investors today, with the S&P/ASX 200 Index (ASX: XJO) recording a slight loss. After spending most of the day in green territ...

The S&P/ASX 200 Index (ASX: XJO) is on course to record a small gain. In afternoon trade, the benchmark index is up 0.2% to 7,698.4 points. Four ASX shares that are rising more than most today are listed below. Here's why they are rac...

24 Apr 2024 - A snapshot of the stocks on the move, featuring Immutep (ASX:IMM; NASDAQ:IMMP), Western Mines Group (ASX:WMG) and Industrial Minerals (ASX:IND).

  Immutep (ASX:IMM; NASDAQ:IMMP) has announced preliminary topline results from Cohort B of the TACTI-003 Phase IIb trial. The trial evaluates efti in combination with MSD’s anti-PD-1 therapy KEYTRUDA® as first-line treatment for recurrent/...

  ASX to extend gains on Wednesday after Wall Street bounced back Tesla surged by 11pc after releasing quarterly results And where will the S&P 500 index be at year end?   Aussie shares are set to extend their good run on Wednesday a...

  The ASX close higher as unemployment rate came in lower than expected Miners rally, led by BHP as the giant released its Q3 report Nimy Resources up 50pc after reporting promising intercepts   The ASX added 0.5% on Thursday as the unemp...

  Nimy Resources (ASX:NIM) advises that drilling at Block 3 within its Mons project in WA has returned intersections of elevated copper, gold, silver mineralisation in massive sulphides plus high-grade gallium and rare earth oxide mineralis...

Immutep Limited (ASX:IMM) has entered into an agreement with the Centre for Human Drug Research (CHDR) in the Netherlands to perform a first-in-human clinical study of IMP761.

The ASX200 slipped into the red – but only by 0.09 of a per cent at close – with Utilities sporting a healthier disposition, up 2.84 per cent, as energy and healthcare slumped around half a per cent. In the green FRE  Australian he...

The ASX200 is up around a quarter of a per cent – beating futures predictions by about half a per cent. Utilities is up around 1.9 per cent – whilst energy and materials are falling off the pace. New Zealand’s inflation data has hit i...

18 Apr 2024 - A snapshot of the stocks on the move, featuring Nimy Resources, New Age Exploration and Immutep.

  Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt provides an update on the company's pipeline of clinical trials, focusing on results in head and neck cancer, lung cancer and breast cancer. Manny Anton: Hello. I'm Manny Ant...

ASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essentially, biotech is a long term game for investors   The S&P/ASX 200 Health Care [XHJ] struggled in February, finishing -1.5% lower and tr...

Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks   There were a couple of big news from the world of biotec...

  Marc Voigt, Executive Director & CEO, Immutep (ASX:IMM) is a clinical-stage biotechnology company at the forefront of developing novel LAG-3 immunotherapy for cancer and autoimmune diseases.

Xi and Biden set to agree on restricting fentanyl  Fentanyl is a synthetic opioid responsible for the opioids epidemic in the US We look at the best performing health stocks over the past couple of weeks   China’s President Xi is expected...

At the $240 million Perennial Better Future Trust, healthcare stocks are a critical component of our ESG-focused portfolio. These stocks, many of which have global reach, have the potential to generate attractive returns while shaping a bet...

ASX health stocks rise in past five days and outpace broader markets Blue chip ResMed slips as US FDA approves weight loss drug Clinical stage immuno-oncology small cap Immutep gains 160%  Morgans healthcare and life sciences expert Iain...

  To register for Friday's webinar click here. Sunstone Metals (ASX:STM) announced the initial Exploration Target shows Limon is on track to be a substantial gold-silver deposit. In response, Sunstone Managing Director Malcolm Norris commen...

09 Nov 2023 - A snapshot of the stocks on the move, featuring Sunstone Metals (ASX:STM), Immutep (ASX:IMM, NASDAQ:IMMP), European Metals Holdings (ASX:EMH & AIM:EMH) and QX Resourc…

ASX to rise despite a muted session on Wall Street Oil plunged another 2pc overnight, possibly signalling a recession S&P released the 10 most shorted stocks on the ASX   Aussie shares are poised to open higher on Thursday as Wall Str...

Immutep (ASX:IMM) has announced that the open-label safety lead-in of its integrated AIPAC-003 Phase 2/3 trial evaluating 90mg of eftilagimod alpha in combination with paclitaxel has been completed with no safety or tolerability iss...

The ASX experienced a subdued Monday session, with its benchmark index nearing 7000 points for the first time in over two weeks, anticipating the Reserve Bank's impending cash rate decision. Australia's central bank is anticipated to raise...

The Australian sharemarket began the week with a slight upward movement, as investors remained watchful for the Reserve Bank's cash rate decision scheduled for Tuesday, with both bond and equity traders exercising caution in their approach....

06 Nov 2023 - A snapshot of the stocks on the move, featuring Whispir (ASX:WSP), QX Resources (ASX:QXR), Immutep (ASX:IMM) and Magnis Energy Technologies (ASX:MNS).

  Soprano Design Australia Pty Ltd today announces its intention to make an off-market takeover bid for all the ordinary shares in Whispir Limited (ASX: WSP) for $0.48 cash per share. The all cash offer price of $0.48 is best and final and...

The Australian stock market has surged around midday, buoyed by the positive performance on Wall Street, amid growing optimism that the Federal Reserve might have concluded its series of interest rate hikes. At noon, the S&P/ASX 200 is...

Immutep (ASX:IMM) announces new biomarker data from its phase II TACTI-002 trial for patients with previously untreated unresectable or metastatic NSCLC Data from blood samples reveals unique immune system stimulation when using efti in...

  To register for today's webinar click here. Findi (ASX:FND) has extended the existing State Bank of India contract until 30 September 2024. Commenting on the SBI contract extension, Findi Chairman Mr Nicholas Smedley said: “The SBI contra...

Welcome to the end of the trading week. ASX futures were up 1.23 per cent (85pts) at 8:30 am AEDT. This implies the ASX will rise after a second green night in the US on the back of a Fed pause. The S&P 500 had its best day since Apr...

03 Nov 2023 - A snapshot of the stocks on the move, featuring Findi (ASX:FND), Immutep (ASX:IMM) and ImpediMed (ASX:IPD).

  Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses progress of the company's drug candidates, highlighting promising data from the  2023 ESMO Congress. Paul Sanger: I'm Paul Sanger for the Finance News Network, and...

Cancer is a nasty disease and the leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths according to World Health Organisation data. Companies and medical facilities worldwide are wor...

On Tuesday, energy and mining stocks drove gains in the Australian sharemarket. Energy stocks benefited from the rise in oil prices, with West Texas Intermediate trading around $86 per barrel. The avoidance of a Gaza invasion by Tel Aviv te...

The ASX200 lifted nearly 0.2 of a per cent by the end of the day’s session, with materials taking a late run to gain .8 of a per cent. Energy also added almost half a per cent.   Cryptocurrency Bitcoin has also jumped almost 10 per cent...

24 Oct 2023 - A snapshot of the stocks on the move, featuring Immutep (ASX:IMM), Empire Energy (ASX:EEG) and Lincoln Minerals (ASX:LML).

  Immutep (ASX:IMM) has reported promising clinical data from the INSIGHT-003 trial at the ESMO Congress 2023. In response, Immutep CSO, commented, “the compelling data that our proprietary MHC Class II agonist has generated in combination...

The spotlight is on RBA Chief Michele Bullock's speech scheduled for 7pm AEDT at the Global Markets Conference hosted by CBA in Sydney. At noon, the S&P/ASX 200 is 0.22 per cent higher at 6,859.30. The SPI futures are pointing to a rise...

The Australian stock market has given up all of the gains that it had made in 2023, with the benchmark S&P/ASX 200 (INDEXASX: XJO) losing 56.6 points, or 0.8%, on Monday to 6,844.1, with resources weakness the major culprit. That puts t...

Australian company Immutep (ASX:IMM) has announced positive data from a trial of its LAG-3 immunotherapy, eftilagimod alpha, in combination with MSD's KEYTRUDA (pembrolizumab).

The ASX200 closed down .8 of a per cent to a new 100-day low. Energy took the biggest hit – losing three per cent and materials wasn’t much better, shedding 2.3 per cent – while healthcare bucked the trend, adding 1.5 per cent. In the...

Benchmark ASX index closes at new 12-month lows Energy and Materials the worst of 9 dipping ASX sectors on Monday Small caps led by CHM, TON   On Monday Aussie markets rediscovered their nadir of the year. No real surprises, since every n...

Australian shares closed at their lowest level in a year on Monday, following a trend set by a weaker Wall Street. This decline was driven by concerns about an escalation of the Middle East conflict, which negatively impacted investor senti...